DE19952956A1 - Verfahren zur Verbindung von molekularen Substanzen - Google Patents

Verfahren zur Verbindung von molekularen Substanzen

Info

Publication number
DE19952956A1
DE19952956A1 DE19952956A DE19952956A DE19952956A1 DE 19952956 A1 DE19952956 A1 DE 19952956A1 DE 19952956 A DE19952956 A DE 19952956A DE 19952956 A DE19952956 A DE 19952956A DE 19952956 A1 DE19952956 A1 DE 19952956A1
Authority
DE
Germany
Prior art keywords
domain
proline
protein
rich
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19952956A
Other languages
German (de)
English (en)
Inventor
Ulrich Schmidt
Constanze Guenther
Christoph Parthier
Gerald Boehm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ACGT Progenomics AG
Original Assignee
ACGT Progenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ACGT Progenomics AG filed Critical ACGT Progenomics AG
Priority to DE19952956A priority Critical patent/DE19952956A1/de
Priority to AU21548/01A priority patent/AU2154801A/en
Priority to AT00984960T priority patent/ATE326984T1/de
Priority to CNB008153167A priority patent/CN100357314C/zh
Priority to DE50012831T priority patent/DE50012831D1/de
Priority to EP00984960A priority patent/EP1227848B1/de
Priority to JP2001535383A priority patent/JP4112859B2/ja
Priority to PCT/EP2000/010873 priority patent/WO2001032684A2/de
Publication of DE19952956A1 publication Critical patent/DE19952956A1/de
Priority to US11/446,587 priority patent/US7807782B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19952956A 1999-11-03 1999-11-03 Verfahren zur Verbindung von molekularen Substanzen Withdrawn DE19952956A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19952956A DE19952956A1 (de) 1999-11-03 1999-11-03 Verfahren zur Verbindung von molekularen Substanzen
AU21548/01A AU2154801A (en) 1999-11-03 2000-11-03 Method for linking molecular substances
AT00984960T ATE326984T1 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen
CNB008153167A CN100357314C (zh) 1999-11-03 2000-11-03 一种分子物质连接的方法
DE50012831T DE50012831D1 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen
EP00984960A EP1227848B1 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen
JP2001535383A JP4112859B2 (ja) 1999-11-03 2000-11-03 分子物質を結合させる方法
PCT/EP2000/010873 WO2001032684A2 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen basierend auf der affinität der prolinreichen aminosäure-sequenzen und proteindomänem vom typ ww
US11/446,587 US7807782B2 (en) 1999-11-03 2006-06-01 Method for linking molecular substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19952956A DE19952956A1 (de) 1999-11-03 1999-11-03 Verfahren zur Verbindung von molekularen Substanzen

Publications (1)

Publication Number Publication Date
DE19952956A1 true DE19952956A1 (de) 2001-05-17

Family

ID=7927813

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19952956A Withdrawn DE19952956A1 (de) 1999-11-03 1999-11-03 Verfahren zur Verbindung von molekularen Substanzen
DE50012831T Expired - Lifetime DE50012831D1 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50012831T Expired - Lifetime DE50012831D1 (de) 1999-11-03 2000-11-03 Verfahren zur verbindung von molekularen substanzen

Country Status (8)

Country Link
US (1) US7807782B2 (https=)
EP (1) EP1227848B1 (https=)
JP (1) JP4112859B2 (https=)
CN (1) CN100357314C (https=)
AT (1) ATE326984T1 (https=)
AU (1) AU2154801A (https=)
DE (2) DE19952956A1 (https=)
WO (1) WO2001032684A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4885476B2 (ja) * 2004-05-21 2012-02-29 株式会社日本触媒 タンパク質及び／又はペプチドの細胞内導入方法
CA2697032C (en) 2007-08-22 2021-09-14 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
US20100189651A1 (en) * 2009-01-12 2010-07-29 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
JP5861223B2 (ja) * 2009-02-23 2016-02-16 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. プロタンパク質およびその使用方法
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
GB201409558D0 (en) 2014-05-29 2014-07-16 Ucb Biopharma Sprl Method
GB201412659D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201601073D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601075D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies molecules
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521391D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521383D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl And Ucb Celltech Method
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521393D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
US11202841B2 (en) * 2018-08-20 2021-12-21 The Trustees Of Indiana University Virus-enabled targeted vector for imaging
CN111979206B (zh) * 2019-05-24 2021-08-17 深圳瑞德林生物技术有限公司 固定化融合酶及用其制备谷胱甘肽的方法
CN117642413A (zh) * 2021-08-31 2024-03-01 富士胶片株式会社 化合物及使用了该化合物的标记生物物质
CN115951051B (zh) * 2022-10-18 2024-01-12 北京卓诚惠生生物科技股份有限公司 一种高灵敏度新型冠状病毒抗原胶体金检测试剂盒及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6072039A (en) 1991-04-19 2000-06-06 Rohm And Haas Company Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
US6503703B1 (en) * 1995-05-19 2003-01-07 Mount Sinai School Of Medicine Of New York University Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US6007544A (en) * 1996-06-14 1999-12-28 Beth Israel Deaconess Medical Center Catheter apparatus having an improved shape-memory alloy cuff and inflatable on-demand balloon for creating a bypass graft in-vivo
US7666221B2 (en) * 2000-05-01 2010-02-23 Endovascular Technologies, Inc. Lock modular graft component junctions
US7044962B2 (en) * 2002-06-25 2006-05-16 Scimed Life Systems, Inc. Implantable prosthesis with displaceable skirt

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. of Virology, Apr. 1999, S. 2921-2929. NATO ASI Series Vol. H 102, 1997, S. 45-48 *

Also Published As

Publication number Publication date
CN100357314C (zh) 2007-12-26
WO2001032684A2 (de) 2001-05-10
DE50012831D1 (de) 2006-06-29
JP4112859B2 (ja) 2008-07-02
AU2154801A (en) 2001-05-14
EP1227848B1 (de) 2006-05-24
US20060252130A1 (en) 2006-11-09
US7807782B2 (en) 2010-10-05
ATE326984T1 (de) 2006-06-15
CN1390140A (zh) 2003-01-08
WO2001032684A3 (de) 2002-04-18
EP1227848A2 (de) 2002-08-07
JP2003517300A (ja) 2003-05-27

Similar Documents

Publication Publication Date Title
EP1227848B1 (de) Verfahren zur verbindung von molekularen substanzen
DE69010206T2 (de) Stabilisierte protein- oder peptidkonjugate.
DE60033405T2 (de) Chimäre polypeptide, verfahren zur herstellung und verwendung dafür
DE69233068T2 (de) Serin-reiche peptidlinker
DE69633175T2 (de) Multimere proteine
EP1270725B1 (de) Anticaline
DE69309472T2 (de) Fusionsproteine von monomeren und dimeren von antikörperfragmenten
EP1675623B1 (de) Ubiquitin oder gamma-kristallin-konjugate zur verwendung in therapie, diagnose und chromatographie
EP2542567B1 (de) Selektive anreicherung von antikörpern
CN109400693A (zh) 新型proNGF突变体及其在生产β-NGF中的用途
DE19618797C2 (de) Vehikel zum Transport molekularer Substanz
WO1996002574A1 (de) Verfahren zur modifizierung der stabilität von antikörpern
DE69033937T2 (de) Verfahren zur Herstellung von genetischen Vektoren zur Expression vom Nerven-Wachstumsfaktor in eukaryotischen Zellen
DE69025211T2 (de) Protein-Antikrebsmittel
DE4344350C2 (de) Bakterien zur Herstellung stabiler Fusionsproteine und Verfahren zu deren Nachweis
CN120399090A (zh) 融合促溶短肽和细胞穿透肽的重组狂犬病病毒纳米抗体及在制备狂犬病防治产品中的应用
WO2012017069A1 (de) Linkerpeptid und seine verwendung in fusionsproteinen
DE19916224C1 (de) Synthetisches biologisch aktives Molekül
EP1232257B1 (de) Modulare transportsysteme für molekulare substanzen und deren herstellung und verwendung
DE60305940T2 (de) Modifizierte therapeutische mittel
EP0453456B1 (de) Pdgf-a, pdgf-aa, pdgf-ab, herstellungsverfahren und sie enthaltende arzneimittel
DE10238846A1 (de) Aktive Fusionsproteine und Verfahren zu ihrer Herstellung
AT511130A2 (de) Polypeptidmaterial mit flexiblen Poreneigenschaften
DE19735105A1 (de) Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen
EP1228199B1 (de) Verfahren zur gerichteten verpackung von molekularen substanzen in proteinhüllen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8139 Disposal/non-payment of the annual fee